Market Cap
$12.7B
QNT
Quantinuum Inc.
$46.14 ▼ -1.16%
Prev close $46.68Market cap$12.7B
ConsensusStrong Buy
12-mo target$97.17 (+110.6%)
▲ Bullish
Analyst conviction 9/10
Insider Buying Cluster (11 insiders)High Impact Filing (7/10)38 New Institutional Positions
Snapshot
The big-picture read on QNT right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Strong Buy (88%)
Inst. Holders
50 funds
Inst. Value
$2.3B
Inst. Activity
38 buys / 0 sells
Insider Activity
$24.7M buy / $0.00 sell
Insider Net $
$24.7M
Social Sentiment
58° Warm
SEC Reports
9
Price chart 30d -3.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 29, 2026 short_volume
Aug 16, 2026 SEC Short Volume: QNT — 79.2% short (0.5M / 0.7M)
Short: 528,797 | Exempt: 6,559 | TRF Vol: 667,451 | Short Ratio: 79.2% | Off-exchange volume (dark p
13 institutional investors initiated new positions in Quantinuum (QNT) during 2026-Q2, accumulating $796.1M in aggregate
INST-CLUSTER — Impact 7/10
Quantinuum announced it will release Q2 2026 financial results on August 11, 2026, after market close, with a conference
PRESS-RELEASE — Impact 1/10
Jul 17, 2026 Insider
Schulman Robin was granted 78,125 shares
CLO & Corporate Secretary
Jul 17, 2026 Insider
Schulman Robin was granted 125,000 shares
CLO & Corporate Secretary
Jun 30, 2026 Inst.
Capital World Investors — NEW
4,558,976 shares ($372.7M)
Jun 30, 2026 Inst.
Jun 8, 2026 SEC CITADEL ADVISORS LLC — NEW
2,299,997 shares ($188.0M)
Director Kenneth Denman purchased $840,000 worth of QNT shares at $60/share over a one-week window, a conviction buy by
INSIDER-BUY — Impact 5/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
88% rate it Buy or better · 17 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 19, 2026 | Rosenblatt | MAINTAIN | Buy | 54% |
| Aug 12, 2026 | Bernstein | MAINTAIN | Outperform | 51% |
| Aug 12, 2026 | Rosenblatt | MAINTAIN | Buy | 54% |
| Aug 12, 2026 | Needham | REITERATE | Buy | 50% |
| Aug 12, 2026 | Cantor Fitzgerald | REITERATE | Overweight | 49% |
| Jun 29, 2026 | Morgan Stanley | INITIATE | Equal-Weight | 55% |
| Jun 29, 2026 | TD Cowen | INITIATE | Buy | 56% |
| Jun 29, 2026 | UBS | INITIATE | Buy | 55% |
| Jun 29, 2026 | JP Morgan | INITIATE | Overweight | 55% |
| Jun 29, 2026 | Jefferies | INITIATE | Buy | 53% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% | |
| Aug 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% | |
| Jul 1, 2026 | 4 | 11 | 2 | 0 | 0 | 88% |
Price targets
Where 12 covering analysts think QNT trades over the next 12 months.
$97.17 +110.6% upside Strong Buy
Current$46.14 Low$78.00 Median$94.00 High$155.00 12 analysts
$78.00$155.00
Analyst rating Strong Buy· 1.3/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
58°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
9 SEC filing reports analyzed · 4 bullish, 0 bearish, 0 mixed, 5 neutral · avg impact 4.8/10.
BULLISHINST-CLUSTER7/10
13 institutional investors initiated new positions in Quantinuum (QNT) during 2026-Q2, accumulating
Aug 16, 2026
NEUTRALPRESS-RELEASE1/10
Quantinuum announced it will release Q2 2026 financial results on August 11, 2026, after market clos
Jul 27, 2026
BULLISHINSIDER-BUY5/10
Director Kenneth Denman purchased $840,000 worth of QNT shares at $60/share over a one-week window,
Jun 8, 2026
BULLISHCLUSTER6/10
Two directors purchased $2.04M in QNT stock at $60/share, joining a broader cluster that includes th
Jun 8, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 29, 2026
short_volume
Short Volume: QNT — 79.2% short (0.5M / 0.7M)
Short: 528,797 | Exempt: 6,559 | TRF Vol: 667,451 | Short Ratio: 79.2% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: QNT — 61.8% short (0.5M / 0.9M)
Short: 533,140 | Exempt: 171 | TRF Vol: 862,515 | Short Ratio: 61.8% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: QNT — 73.3% short (0.6M / 0.8M)
Short: 561,385 | Exempt: 11 | TRF Vol: 765,501 | Short Ratio: 73.3% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: QNT — 61.9% short (0.7M / 1.1M)
Short: 692,941 | Exempt: 5,100 | TRF Vol: 1,119,966 | Short Ratio: 61.9% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: QNT — 71.7% short (0.8M / 1.1M)
Short: 773,753 | Exempt: 933 | TRF Vol: 1,079,777 | Short Ratio: 71.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.37 | $-0.49–$-0.31 | — | -7.2% | 3↑ 5↓ | $0.0B | 10 |
| Next Q | $-0.39 | $-0.48–$-0.33 | — | -2.6% | 4↑ 4↓ | $0.0B | 10 |
| Current FY | $-1.41 | $-1.79–$-1.00 | — | +0.1% | 5↑ 5↓ | $0.0B | 10 |
| Next FY | $-1.60 | $-1.94–$-1.48 | -12.9% | +0.1% | 3↑ 5↓ | $0.1B | 10 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.374 | — |
| 7d ago | $-0.374 | — |
| 30d ago | $-0.349 | -0.025 |
| 60d ago | $-0.349 | -0.025 |
| 90d ago | $0.000 | -0.374 |
Institutional ownership
Which big funds own QNT (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $2.3B total value (27,701,542 shares) as of 2026-Q2. Top holders: Capital, CITADEL, BlackRock,. Net buying activity: 38 institutions added/increased vs 0 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| Capital World Investors | 4,558,976 | $372.7M | 16.5% | NEW |
| CITADEL ADVISORS LLC | 2,299,997 | $188.0M | 8.3% | NEW |
| BlackRock, Inc. | 2,259,347 | $184.7M | 8.2% | NEW |
| Capital Research Global Investors | 1,754,325 | $143.4M | 6.3% | NEW |
| WELLINGTON MANAGEMENT GROUP LLP | 1,130,639 | $92.4M | 4.1% | NEW |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,028,382 | $84.1M | 3.7% | NEW |
| Capital International Investors | 961,428 | $78.6M | 3.5% | NEW |
| VANGUARD CAPITAL MANAGEMENT LLC | 949,283 | $77.6M | 3.4% | NEW |
| BALYASNY ASSET MANAGEMENT L.P. | 821,918 | $67.2M | 3.0% | NEW |
| ALLIANCEBERNSTEIN L.P. | 789,326 | $64.5M | 2.8% | NEW |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Capital World Investors | NEW | — | 4,558,976 | — | $372.7M |
| CITADEL ADVISORS LLC | NEW | — | 2,299,997 | — | $188.0M |
| BlackRock, Inc. | NEW | — | 2,259,347 | — | $184.7M |
| Capital Research Global Investors | NEW | — | 1,754,325 | — | $143.4M |
| WELLINGTON MANAGEMENT GROUP LLP | NEW | — | 1,130,639 | — | $92.4M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | NEW | — | 1,028,382 | — | $84.1M |
| Capital International Investors | NEW | — | 961,428 | — | $78.6M |
| VANGUARD CAPITAL MANAGEMENT LLC | NEW | — | 949,283 | — | $77.6M |
| BALYASNY ASSET MANAGEMENT L.P. | NEW | — | 821,918 | — | $67.2M |
| ALLIANCEBERNSTEIN L.P. | NEW | — | 789,326 | — | $64.5M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 27 transactions. Net $24.7M — $24.7M bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | Schulman Robin | CLO & Corporate Secretary | AWARD | 78,125 | — | — |
| Jul 17, 2026 | Schulman Robin | CLO & Corporate Secretary | AWARD | 125,000 | — | — |
| Jun 5, 2026 | Daugherty Paul R. | Director | BUY | 4,000 | $60.00 | $240.0K |
| Jun 5, 2026 | Barron Hal | Director | BUY | 250,000 | $60.00 | $15.0M |
| Jun 5, 2026 | JIMENEZ JOSEPH | Director | BUY | 66,665 | $60.00 | $4.0M |
| Jun 5, 2026 | SHARAN NITESH | Chief Financial Officer | BUY | 6,500 | $60.00 | $390.0K |
| Jun 5, 2026 | Kapur Vimal | Director | BUY | 13,000 | $60.00 | $780.0K |
| Jun 5, 2026 | Branderiz Eric | Director | BUY | 8,334 | $60.00 | $500.0K |
| Jun 5, 2026 | Stepniak Michal | Director | BUY | 13,333 | $60.00 | $800.0K |
| Jun 5, 2026 | DENMAN KENNETH D | Director | BUY | 14,000 | $60.00 | $840.0K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for QNT.
Shares short
3,715,253
Settlement Sep 15, 2026
Change vs prior
+29.1%
Semi-monthly cycle
Days to cover
2.5
At avg daily volume
Of shares outstanding
≈1.4%
Estimate — not % of float
All QNT filing & press-release reports (9)
- INST-CLUSTER reportAug 16, 2026
- PRESS-RELEASE reportJul 27, 2026
- INSIDER-BUY reportJun 8, 2026
- CLUSTER reportJun 8, 2026
- 3 reportJun 4, 2026
- 3 reportJun 4, 2026
- EFFECT reportJun 4, 2026
- S-1/A reportJun 1, 2026
- S-1/A reportMay 26, 2026